Data on sprytne.com is aggregated from official U.S. Government sources including the SEC EDGAR database, USAspending.gov, USPTO, and U.S. Census Bureau. In accordance with 17 U.S.C. § 105, works of the U.S. Government are not subject to copyright protection and reside in the Public Domain. sprytne.com provides value-added visualization and algorithmic analysis of these public records.
Not financial advice. sprytne.com is an automated market intelligence platform. We are not a registered investment advisor, broker, or dealer. Financial metrics, risk scores, and federal award data are for informational purposes only. Past performance (including government contract history) is not indicative of future market results. Verify all data via official SEC.gov filings.
This platform adheres to CCPA/GDPR standards regarding professional and public business data. Information displayed pertains to commercial entities and public officers in their professional capacity. For data verification or removal requests regarding non-public information, please visit our Contact page. Operated under Brand House Data Systems framework.
© 2026 sprytne.com — Institutional Data Intelligence — Federal Transparency Initiative
Free, citation-ready research reports on US companies and industries. All data sourced from SEC EDGAR and public government datasets.
Analysis of 2811 SEC-registered companies incorporated in Delaware, broken down by industry sector. Delaware is the incorporation capital of the US, home to over 65% of Fortune 500 companies.
A data-driven ranking of the 100 largest US-listed pharmaceutical companies by most recent annual revenue, sourced from SEC EDGAR XBRL filings. Covers SIC codes 2830–2836 (drugs, biologics, diagnostic substances).